A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/2009
12/10/2009	WO2009147635A1 Fulvic acid and antibiotic combination
12/10/2009	WO2009147439A1 Anti-tumoural effects of cannabinoid combinations
12/10/2009	WO2009147438A1 Cannabinoids in combination with non -cannabinoid chemotherapeutic agents (e.g. serm or alkylating agents)
12/10/2009	WO2009147169A1 Pharmaceuticl compositions useful for the treatment of cancers, in particular acute myeloid leukemia and acute promyelocytic leukemia
12/10/2009	WO2009147009A2 Compositions comprising atorvastatin 4-(nitrooxy) butyl ester and a hypolipidemic drug
12/10/2009	WO2009126682A3 Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
12/10/2009	US20090306230 High Throughput Testing for Presence of Microorganisms in a Biological Sample
12/10/2009	US20090306104 Use of Lck inhibitors for treatment of immunologic diseases
12/10/2009	US20090306098 Combination of roscovitine and a hdca inhibitor to treat proliferative diseases
12/10/2009	US20090306095 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
12/10/2009	US20090306012 Therapeutic protocols
12/10/2009	US20090305992 Use of an interleukin 1 receptor antagonist and/or pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes
12/10/2009	US20090305989 Composition and method for potentiating drugs
12/10/2009	US20090305411 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors
12/10/2009	US20090304765 R-ras activity in vascular regulation
12/10/2009	US20090304744 Methods of enhancing immune response in the intradermal compartment and compounds useful thereof
12/10/2009	US20090304709 Modulators of p-selectin glycoprotein ligand 1
12/10/2009	US20090304708 Preparation for the Prevention and/or Treatment of a Tissue Change of Mesenchymal Origin
12/10/2009	US20090304663 Use of gsk-3 inhibitors for the treatment of prostate cancer
12/10/2009	US20090304661 Method And Composition For Proctecting Neuronal Tissue From Damage Induced By Elevated Glutamate Levels
12/10/2009	US20090304654 Methods for isolating adipose-derived stem cells and therapeutic use thereof
12/10/2009	US20090304653 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
12/10/2009	US20090304647 Production of Neural Stem Cells from Bone Marrow Tissue and Use Thereof
12/10/2009	US20090304639 Method for preparing an organ for transplantation
12/10/2009	US20090304635 Methods for generating new hair follicles, treating baldness, and hair removal
12/10/2009	US20090304577 Peptides for Treatment and Diagnosis of Autoimmune Disease
12/10/2009	CA2726833A1 Pharmaceutical compositions for treatment of parkinson's disease
12/10/2009	CA2726258A1 Anti-tumoural effects of cannabinoid combinations
12/10/2009	CA2726257A1 Cannabinoids in combination with non-cannabinoid chemotherapeutic agents (e.g. serm or alkylating agents)
12/10/2009	CA2724873A1 Compositions comprising atorvastatin 4-(nitrooxy) butyl ester and a hypolipidemic drug
12/09/2009	EP2130920A2 Beta-like glycoprotein hormone polypeptide and heterodimer
12/09/2009	EP2130828A1 Sulfonamide derivative
12/09/2009	EP2130534A1 Use of ritonavir for improving the pharmacokinetics of drugs metabolized by cytochrome P450
12/09/2009	EP2130532A1 Method for treating conditions associated with the accumulation of excess extracellular matrix
12/09/2009	EP2129382A1 Compositions and methods for tranquilizing heart muscle
12/09/2009	EP1722802B1 A medical solution, a method for producing said medical solution and use thereof
12/09/2009	EP1679370B1 Method of evaluating cancerization degree
12/09/2009	EP1648493B1 Inhibition of tumor angiogenesis by combination of thrombospondin-1 and inhibitors of vascular endothelial growth factor
12/09/2009	EP1458754B1 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
12/09/2009	EP1443933B1 Treatment of chronic myelogenous leukemia, resistant or intolerant to sti571, involving homoharringtonine alone or combined with other agents
12/09/2009	EP1129110B1 Platelet-derived growth factor d, dna coding therefor, and uses thereof
12/09/2009	EP1119614B1 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof
12/09/2009	CN101600474A 1,3-dihydroimidazoles for treating cardiovascular disorders
12/09/2009	CN101600458A Combination therapy of lower urinary tract disorders with a2d ligands and nsaids
12/09/2009	CN101600440A Pharmaceutical composition comprising a pyrazole-O-glucoside derivative
12/09/2009	CN101597337A Conjugate of hydroxyalkyl starch and an active agent
12/09/2009	CN101597262A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/09/2009	CN101596318A External preparation for treating androgens psilosis, seborrheic dermatitis and acne
12/09/2009	CN101596317A Composition containing tanshinone ingredient and HMG-CoA reductase inhibitor and application thereof
12/09/2009	CN101596316A Recombinant adenovirus expressing FoxMlsiRNA and application of tumor therapy and prevention thereof
12/09/2009	CN101596187A Anti-cancer combinations
12/09/2009	CN101596186A Anti-cancer combinations
12/09/2009	CN100567322C Polypeptide for inhibiting growth differentiation factor activity and cell expressing the same
12/09/2009	CN100567266C Cannabinoid receptor ligands
12/09/2009	CN100566754C Gelling agent for controlling and releasing 5-HT3 acceptor antagon and method of preparing the same
12/09/2009	CN100566722C Method and composition for treatment of adenoviral ocular infections
12/09/2009	CN100566711C Compound for the treatment of cancer and use thereof
12/09/2009	CN100566708C Method of producing hepatic targeting drug microcapsule
12/08/2009	US7629477 mitotic kinesins like KSP inhibitors; for treating cellular proliferative diseases; N-(3-Aminopropyl)-N [(R)-1-3-benzyl-7-chloro-4-oxo-4H-chromen-2-yl)-2-methyl-propyl]-4-methyl-benzamide
12/08/2009	US7629337 Chemokine receptor binding heterocyclic compounds
12/08/2009	US7629330 Use of zwitterionic polysaccharides for the specific modulation of immune processes
12/08/2009	US7629318 Immunosuppressant compounds, methods and uses related thereto
12/08/2009	US7629311 Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers
12/08/2009	US7629308 Methods relating to muscle selective calcineurin interacting protein (MCIP)
12/08/2009	US7629003 Esters of L-carnitine of alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
12/08/2009	US7628991 Use of Lactobacillus farciminis for the prevention or treatment of digestive pathologies
12/08/2009	US7628988 Induce cell differentiation; process control
12/08/2009	US7628987 Vectors derived from antibodies for transferring substances into cells
12/08/2009	US7628982 Boosting an immune response in an animal; vaccine containing B. subtilis spores, in the presence or absence of an antigen
12/08/2009	US7628978 Stabilized preparations for use in metered dose inhalers
12/08/2009	US7628765 Increasing retrievable cells from a breast duct
12/08/2009	CA2422354C Pyrazole compounds useful as protein kinase inhibitors
12/08/2009	CA2422342C Novel amide derivatives and medicinal use thereof
12/08/2009	CA2389025C Hormonal composition based on a progesterone and an oestrogen and use thereof
12/08/2009	CA2386720C Alcohol based topical anesthetic formulation and method
12/08/2009	CA2359242C Growth differentiation factor inhibitors and uses therefor
12/08/2009	CA2358289C Amide derivatives for antiangiogenic and/or antitumorigenic use
12/08/2009	CA2347907C Formulations for topical application of substances having an antiandrogenic action
12/08/2009	CA2333076C Topical application of muscarinic analgesic drugs such as neostigmine
12/08/2009	CA2322865C Pharmaceutical compositions for ulcer
12/08/2009	CA2302275C Solid solution beadlet
12/03/2009	WO2009146456A1 Controlled release of growth factors and signaling molecules for promoting angiogenesis
12/03/2009	WO2009145921A1 Method and composition for skin inflammation and discoloration
12/03/2009	WO2009145619A1 Antibiotic composition
12/03/2009	WO2009145358A2 Medicament for the prophylaxis or treatment of hypertension
12/03/2009	WO2009145289A1 Inhibitor of analgesic tolerance
12/03/2009	WO2009144719A2 Methods of killing cells and use of same in prevention and treatment of cancer
12/03/2009	WO2009144473A1 Antifungal combination therapy
12/03/2009	WO2009144268A1 Composition for increasing gastrointestinal transit time
12/03/2009	WO2009144220A1 Water soluble curcumin compositions for use in anti-cancer and anti-inflammatory therapy
12/03/2009	WO2009143662A1 Pharmaceutical composition comprising calcium blocker and b family vitamins and the use thereof
12/03/2009	WO2009143633A1 Pcsk9 inhibitors and methods of use thereof
12/03/2009	WO2009124553A3 Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischemia
12/03/2009	WO2009124551A3 Use of vanilloid receptor agonists as hypothermia inducing drugs for the treatment of ischemia
12/03/2009	WO2009121945A3 Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
12/03/2009	WO2009118191A3 Therapy for vitiligo
12/03/2009	WO2009089260A3 Combination of anti-ctla4 antibody with tubulin modulating agents for the treatment of proliferative diseases
12/03/2009	WO2009075838A3 Treatment of menorrhagia with aromatase inhibitor
12/03/2009	WO2009024677A3 Use of hyaluronic acid for preparing compositions for improving the function of skin, eye and mucous membrane protection
12/03/2009	US20090298873 Methods of reducing microbial resistance to drugs

1 ... 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 ... 1151